Cart
sales@molnova.com
Dihydroactinidiolide
CAS No. 17092-92-1
Dihydroactinidiolide( —— )
Catalog No. M18118 CAS No. 17092-92-1
Dihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 45 | In Stock |
|
| 100MG | 59 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydroactinidiolide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
-
DescriptionDihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17092-92-1
-
Formula Weight180.24
-
Molecular FormulaC11H16O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (554.82 mM)
-
SMILESCC1(CCC[C@@]2(C1=CC(=O)O2)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shumbe L, et al. Dihydroactinidiolide, a high light-induced β-carotene derivative that can regulate gene expression and photoacclimation in Arabidopsis. Mol Plant. 2014 Jul;7(7):1248-51.
molnova catalog
related products
-
dBRD9 HCl
dBRD9 HCl is a PROTAC composed of the BRD9 inhibitor BI 7273 conjugated to the cereblon E3 ligase ligand pomalidomide . dBRD9 HCl is a potent and selective degrader of BRD9 (IC50 = 56.6 nM in MOLM-13 cells).
-
ZEN-3219
ZEN-3219 is a BET inhibitor, which has inhibitory effect on BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2).
-
BRD7-IN-1
BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 via linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively .
